logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
L

Lung Cancer-Targets and Therapy

IF3.3
Papers81
Citations427
Journal Papers 81
Publication Date
delete
Tiered Group of Disease Driven Oncogene Informs Survival Outcome of Taiwanese and Japanese Patients with Advanced NSCLC in the LC-SCRUM-Asia Study
deleteLung Cancer-Targets and Therapy
IF3.3
delete2026-10-13
delete0
deleteOAAI
deleteChih-Hsi Scott Kuo; Shigeki Umemura; Chin-Chou Wang; Shingo Matsumoto; How-Wen Ko; Fu-Tsai Chung; Ping-Chih Hsu; Hiroki Izumi; Yuji Shibata; Hibiki Udagawa; Kiyotaka Yoh; Yuri Murata; Koichi Goto; Cheng-Ta Yang
deleteShare
deleteSave
Can We Extend Beyond 2 Years of Adjuvant ALK TKI Established by ALINA and ELEVATE in Resected Early Stage ALK+ NSCLC a Disease with High Predilection for CNS Metastasis with Novel Clinical Trial Designs?
deleteLung Cancer-Targets and Therapy
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteVivian Thuy Tieu, Misako Nagasaka, Sai-Hong Ignatius Ou
deleteShare
deleteSave
Healing of Post-Operative Tracheal Disruption in a Patient with Thymic Carcinoma on Adjuvant Immunotherapy
deleteLung Cancer-Targets and Therapy
IF3.3
delete2026-09-22
delete0
deleteOAAI
deleteJessica Lubisich; Hari B Keshava; Jeremy P Harris; Tjoson Tjoa; Cathleen J Park; Zhaohui L Arter; Sai-Hong Ignatius Ou; Misako Nagasaka
deleteShare
deleteSave
Identification of JAML as an Immune-Associated Prognostic Marker in Non-Small Cell Lung Cancer
deleteLung Cancer-Targets and Therapy
IF3.3
delete2026-09-02
delete0
deleteOAAI
deleteQin Tian; Fucheng Zhang; Chunyan Han
deleteShare
deleteSave
Unilateral Scleral Icterus as a Rare Presentation of Choroidal Metastasis in Transdifferentiated EGFR-Mutant Lung Cancer: A Case Report and Review of the Literature
deleteLung Cancer-Targets and Therapy
IF3.3
delete2026-08-28
delete0
deleteOAAI
deleteOz Levinkron; Thubeena Manickavasagar; Sanjay Popat; Richard Scawn
deleteShare
deleteSave
Response to Selpercatinib in a CCDC6-RET Lung Adenocarcinoma with an Acquired Novel RET p.L730_G731insL After Progression on Pralsetinib: A Case Report
deleteLung Cancer-Targets and Therapy
IF3.3
delete2026-05-20
delete0
deleteOAAI
deleteChunyu Tian; Yang Zou; Jinxin Liu; Jing Zhao; Simiao Tian; Ying Liu; Gang Wang
deleteShare
deleteSave
Efficiency of Immunological Blood Biomarkers in Predicting Chemotherapy Response and Survival Outcome for Non-Targetable Advanced Non-Small Cell Lung Cancer Patients
deleteLung Cancer-Targets and Therapy
IF3.3
delete2026-01-01
delete0
deleteOAAI
deleteLumjiaktase, Putthapoom; Kemawichanurat, Nanthisa; Santiwiwas, Kanthon; Kuttiyod, Thatchathum; Oranratnachai, Songporn; Trachu, Narumol; Monnamo, Nanamon; Khiewngam, Khantong; Simmalee, Kantapat; Reungwetwattana, Thanyanan
deleteShare
deleteSave
Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)
deletelung cancer targets and therapy
IF0
delete2025-08-12
delete0
deleteOAAI
deleteRenaud Descourt; Florian Guisier; Maurice Pérol; Jacques Cadranel; Helene Doubre; Michael Duruisseaux; Stéphane Culine; Bertrand Mennecier; Olivier Bylicki; Christos Chouaid; Laurent Greillier
deleteShare
deleteSave
Epidermal Growth Factor Receptor Kinase Domain Duplication in Lung Adenocarcinoma with Sensitive Response to Afatinib: A Case Report and Literature Review
deletelung cancer targets and therapy
IF0
delete2025-08-12
delete0
deleteOAAI
deleteShuangru Chen; Liting Zhang; Jun Wang; Jiayao Lu; Ye Chen; Mingzhu Ling
deleteShare
deleteSave
Genomic and Transcriptomic Profiles in Smokers and Never-Smokers Lung Squamous Cell Carcinoma Patients
deletelung cancer targets and therapy
IF0
delete2025-06-28
delete0
deleteOAAI
deleteMatteo Canale; Alessandra Virga; Davide Angeli; Eugenio Fonzi; Letizia Gnetti; Alessandra Dubini; Gianluca Tedaldi; Milena Urbini; Giovanni Bocchialini; Elisabetta Petracci; Alberto Verlicchi; Paola Cravero; Fabrizio Citarella; Chiara Bennati; Kalliopi Andrikou; Angelo Delmonte; Lucio Crinò; Paolo Carbognani; Paola Ulivi; Luca Ampollini
deleteShare
deleteSave
Evaluation of the Effectiveness and Safety Profile of First-Line Immune Checkpoint Inhibitors Combined with Chemotherapy in Pulmonary Sarcomatoid Carcinoma
deletelung cancer targets and therapy
IF0
delete2025-06-09
delete0
deleteOAAI
deleteHe Du, Xinyu Song, Fengying Wu
deleteShare
deleteSave
Elucidating the Role of FASN in Lung Cancer Stem Cells in Sensitive and Resistant EGFR-Mutated Non-Small Cell Lung Cancer Cells
deletelung cancer targets and therapy
IF0
delete2025-05-27
delete0
deleteOAAI
deleteEmma Polonio-Alcalá; Sira Ausellé-Bosch; Gerard Riesco-Llach; Pablo Novales; Lidia Feliu; Marta Planas; Joaquim Ciurana; Teresa Puig
deleteShare
deleteSave
LAURA Completes the Osimertinib Treatment Jigsaw Puzzle of EGFR+ NSCLC from Stage IB to IV: Adjuvant Osimertinib Significantly Improves PFS and CNS Progression in Unresectable Stage III EGFR-Mutated NSCLC Compared to Placebo (LAURA; NCT03521154)
deletelung cancer targets and therapy
IF0
delete2025-04-25
delete0
deleteOAAI
deleteFaustine X Luo; Zhaohui Arter; Sai-Hong Ignatius Ou; Misako Nagasaka
deleteShare
deleteSave
Prevalence of EGFR Mutations in Vietnamese Patients with Resected Early Stage Non-Small Cell Lung Cancer: EARLY-EGFR Study
deletelung cancer targets and therapy
IF0
delete2025-04-21
delete0
deleteOAAI
deleteTu Van Dao; Van Luong Dinh; Thanh Vinh Doan; Tri Le Phuong
deleteShare
deleteSave
Impact of Subsequent Treatment on Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Transformed to Small-Cell Lung Cancer
deletelung cancer targets and therapy
IF0
delete2025-04-12
delete0
deleteOAAI
deleteChing-Yi Chen; How-Wen Ko; Po-Wei Hu; Cheng-Yu Chang; Chung-Yu Chen; Shih-Chieh Chang; Yu-Chi Chiu; Yu-Feng Wei
deleteShare
deleteSave
Comprehensive Survey of AACR GENIE Database of Tumor Mutation Burden (TMB) Among All Three Classes (I; II; III) of BRAF Mutated (BRAF+) NSCLC
deletelung cancer targets and therapy
IF0
delete2025-02-19
delete0
deleteOAAI
deleteZhaohui Liao Arter; Kevin Shieh; Misako Nagasaka; Sai-Hong Ignatius Ou
deleteShare
deleteSave
Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival
deleteLUNG CANCER-TARGETS AND THERAPY
IF3.3
delete2025-02-01
delete0
deleteOAAI
deleteCanale, Matteo; Urbini, Milena; Petracci, Elisabetta; Angeli, Davide; Tedaldi, Gianluca; Priano, Ilaria; Cravero, Paola; Flospergher, Michele; Andrikou, Kalliopi; Bennati, Chiara; Tassinari, Davide; Dubini, Alessandra; Rossi, Giulio; Panzacchi, Riccardo; Valli, Mirca; Bronte, Giuseppe; Crino, Lucio; Delmonte, Angelo; Ulivi, Paola
deleteShare
deleteSave
Adagrasib in KRYSTAL-12 has Not Broken the KRAS G12C Enigma Code of the Unspoken 6-Month PFS Barrier in NSCLC
deleteLUNG CANCER-TARGETS AND THERAPY
IF3.3
delete2024-12-01
delete0
deleteOAAI
deleteLee, Alexandria T. M.; Nagasaka, Misako
deleteShare
deleteSave
Adagrasib in KRYSTAL-12 has Broken the KRASG12C Enigma Code in Non-Small Cell Lung Carcinoma
deleteLUNG CANCER-TARGETS AND THERAPY
IF3.3
delete2024-10-01
delete0
deleteOAAI
deleteLuo, Faustine X.; Arter, Zhaohui Liao
deleteShare
deleteSave
NRG1 Fusions in NSCLC: Being eNRGy Conscious
deleteLUNG CANCER-TARGETS AND THERAPY
IF3.3
delete2024-10-01
delete1
deleteOAAI
deleteGupta, Brinda; Barrett, Laura Gosa; Liu, Stephen, V
deleteShare
deleteSave